HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Kitajima Selected Research

Stomach Neoplasms (Stomach Cancer)

7/2004Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation.
12/2001The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice.
10/2001[Clinical significance of sentinel node navigation surgery in the treatment of early gastric cancer].
10/2001Cyclin D1 antisense oligonucleotide inhibits cell growth stimulated by epidermal growth factor and induces apoptosis of gastric cancer cells.
3/2000Integrin alpha6beta4 as a suppressor and a predictive marker for peritoneal dissemination in human gastric cancer.
1/2000Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Kitajima Research Topics

Disease

32Neoplasms (Cancer)
04/2017 - 01/2000
13Breast Neoplasms (Breast Cancer)
01/2010 - 03/2000
7Carcinoma (Carcinomatosis)
01/2007 - 04/2000
6Stomach Neoplasms (Stomach Cancer)
07/2004 - 01/2000
5Neoplasm Metastasis (Metastasis)
06/2006 - 03/2000
5Colorectal Neoplasms (Colorectal Cancer)
05/2003 - 09/2001
4Infections
04/2018 - 07/2004
4Esophageal Neoplasms (Esophageal Cancer)
04/2014 - 01/2000
4Lymphatic Metastasis
01/2010 - 03/2000
4Esophageal Squamous Cell Carcinoma
12/2005 - 01/2000
4Carcinogenesis
12/2005 - 03/2000
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2001 - 01/2000
4Pancreatic Neoplasms (Pancreatic Cancer)
05/2001 - 03/2000
2Obesity
08/2011 - 05/2001
2Acute Lung Injury
01/2007 - 01/2006
2Ischemia
11/2001 - 07/2001
2Hepatocellular Carcinoma (Hepatoma)
12/2000 - 03/2000
1COVID-19
01/2021
1Diabetes Mellitus
07/2020
1Acute Kidney Injury (Acute Renal Failure)
07/2020
1Chronic Kidney Failure (Chronic Renal Failure)
07/2020
1Parkinson Disease (Parkinson's Disease)
05/2016
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
05/2013
1Astrocytoma (Pilocytic Astrocytoma)
09/2008
1Oxyphilic Adenoma (Oncocytoma)
01/2008
1End Stage Liver Disease
09/2007
1Sclerosing Cholangitis
09/2007
1Hemangioma (Angioma)
03/2007
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2007
1Adenocarcinoma
08/2006
1Disease Progression
01/2006
1Septic Shock (Toxic Shock Syndrome)
01/2006
1Sepsis (Septicemia)
01/2006
1Esophagitis
12/2005

Drug/Important Bio-Agent (IBA)

5Indicators and Reagents (Reagents)IBA
06/2006 - 01/2000
3Biomarkers (Surrogate Marker)IBA
07/2020 - 12/2005
3DNA (Deoxyribonucleic Acid)IBA
04/2018 - 03/2000
3Coloring Agents (Dyes)IBA
03/2012 - 10/2001
3Proteins (Proteins, Gene)FDA Link
01/2006 - 05/2001
3Fluorouracil (Carac)FDA LinkGeneric
05/2003 - 01/2000
3Pharmaceutical PreparationsIBA
12/2001 - 07/2000
37-hydroxystaurosporine (UCN 01)IBA
05/2001 - 07/2000
3EnzymesIBA
04/2000 - 01/2000
2Genetic Markers (Genetic Marker)IBA
04/2018 - 03/2000
2IronIBA
05/2016 - 03/2007
2InterleukinsIBA
01/2008 - 07/2001
2Therapeutic UsesIBA
01/2007 - 10/2001
2Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2007 - 06/2000
2Cyclin D1IBA
12/2005 - 10/2001
2IodineIBA
12/2005 - 04/2000
2Fluorescent Dyes (Fluorescent Probes)IBA
10/2004 - 07/2000
2FlavonoidsIBA
07/2004 - 12/2001
2nobiletinIBA
07/2004 - 12/2001
2Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
05/2003 - 01/2000
2Thymidylate SynthaseIBA
05/2003 - 01/2000
2Methotrexate (Mexate)FDA LinkGeneric
07/2002 - 07/2001
2Matrix Metalloproteinases (MMPs)IBA
12/2001 - 04/2000
2Epidermal Growth Factor (EGF)IBA
10/2001 - 01/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
07/2001 - 01/2001
2Aromatase InhibitorsIBA
07/2001 - 07/2000
2Hormones (Hormone)IBA
07/2001 - 07/2000
2AnthracyclinesIBA
07/2001 - 01/2001
2Antineoplastic Agents (Antineoplastics)IBA
05/2001 - 07/2000
2Triglycerides (Triacylglycerol)IBA
05/2001 - 04/2000
2Messenger RNA (mRNA)IBA
11/2000 - 01/2000
2CollagenIBA
07/2000 - 04/2000
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2000 - 03/2000
1WastewaterIBA
01/2021
1Ion Channels (Ion Channel)IBA
04/2018
1Disinfectants (Biocides)IBA
07/2015
1N-trifluoroacetyladriamycinIBA
05/2013
1Drinking WaterIBA
07/2010
1Radioisotopes (Radionuclides)IBA
01/2010
1Interleukin-6 (Interleukin 6)IBA
01/2008
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2007
1Ganciclovir (Cytovene)FDA LinkGeneric
01/2007
1Green Fluorescent ProteinsIBA
01/2007
1polymyxin B nonapeptideIBA
01/2007
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2007
1Thymidine KinaseIBA
01/2007
1ProdrugsIBA
01/2007
1Interleukin-2 (IL2)IBA
01/2007
1sivelestatIBA
01/2007
1SodiumIBA
01/2007
1Paclitaxel (Taxol)FDA LinkGeneric
01/2007
1N-acetoacetyl-N-deacetylcolchicineIBA
08/2006

Therapy/Procedure

10Therapeutics
06/2006 - 04/2000
5Lymph Node Excision (Lymph Node Dissection)
08/2004 - 08/2000
4Esophagectomy
04/2014 - 08/2000
3Drug Therapy (Chemotherapy)
06/2005 - 07/2000
2Immunotherapy
04/2017 - 09/2014
2Aftercare (After-Treatment)
09/2014 - 12/2000
2Colectomy
04/2003 - 09/2001
2Thyroidectomy
09/2001 - 02/2000
2Gastrectomy
09/2001 - 01/2000
2Surgical Instruments (Clip)
07/2001 - 03/2000
1Hip Replacement Arthroplasty (Total Hip Replacement)
07/2020
1Nutritional Support (Artificial Feeding)
04/2014
1Bariatric Surgery
08/2011
1Liver Transplantation
09/2007